Immunohistochemical Changes After Neoadjuvant Chemotherapy and Their Impact on Breast Cancer Survival: A Systematic Review and Meta-analysis
Authors:
- Marcelo AntoniniMAMarcelo Antonini
- André MattarAndré Mattar
- Gil FacinaGFGil Facina
- Francisco Pimentel CavalcanteFCFrancisco Pimentel Cavalcante
- Felipe ZerwesFZFelipe Zerwes
- Fabricio Palermo BrenelliFBFabricio Palermo Brenelli
- Antônio Luis FrassonAFAntônio Luis Frasson
- Eduardo Camargo MillenEMEduardo Camargo Millen
- Rodrigo Caires CamposRCRodrigo Caires Campos
- Letícia Xavier FélixLFLetícia Xavier Félix
- Juliana Calado VieiraJVJuliana Calado Vieira
- Marina Diógenes TeixeiraMTMarina Diógenes Teixeira
- 1 November 2025
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 26 (3) , 208-222.e11
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systemsThe Breast, 2025
- Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trialNature Medicine, 2025
- Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trialNature Medicine, 2025
- Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast CancerJAMA Oncology, 2024
- Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysisClinical and Translational Oncology, 2024
- PRISMA2020 : An R package and Shiny app for producing PRISMA 2020‐compliant flow diagrams, with interactivity for optimised digital transparency and Open SynthesisCampbell Systematic Reviews, 2022
- Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancerJournal of Surgical Oncology, 2017
- Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?Human Pathology, 2017
- Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression – Implications for the practising oncologistEuropean Journal of Cancer, 2016
- Changes in ER, PR and HER2 receptors status after neoadjuvant chemotherapy in breast cancerPathology - Research and Practice, 2013